Atenolol

Generic name: Pronounced as (a ten' oh lole)
Brand names
  • Tenormin®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 10/15/2017

Do not stop taking atenolol without talking to your doctor. Suddenly stopping atenolol may cause chest pain, heart attack, or irregular heartbeat. Your doctor will probably decrease your dose gradually.

Atenolol is used alone or in combination with other medications to treat high blood pressure. It also is used to prevent angina (chest pain) and improve survival after a heart attack. Atenolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Atenolol comes as a tablet to take by mouth. It is usually taken once or twice a day. To help you remember to take atenolol, take it around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take atenolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Atenolol controls high blood pressure and angina but does not cure them. It may take 1-2 weeks before you feel the full benefit of atenolol. Continue to take atenolol even if you feel well. Do not stop taking atenolol without talking to your doctor.

Atenolol is also used sometimes to prevent migraine headaches and to treat alcohol withdrawal, heart failure, and irregular heartbeat. Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking atenolol,

  • tell your doctor and pharmacist if you are allergic to atenolol, any other medications, or any of the ingredients in atenolol tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: calcium channel blockers such as diltiazem (Cardizem, Cartia XT, Dilacor XR, Tiazac, others) and verapamil (Calan, Covera-HS, Verelan, in Tarka); clonidine (Catapres, Kapvay, in Clorpres); nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin (Indocin, Tivorbex); and reserpine. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma or other lung diseases; diabetes; severe allergies; hyperthyroidism (an overactive thyroid gland); pheochromocytoma (a tumor that develops on a gland near the kidneys and may cause high blood pressure and fast heartbeat); heart failure; a slow heart rate; circulation problems; or heart or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking atenolol, call your doctor immediately.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking atenolol.

  • you should know that if you have allergic reactions to different substances, your reactions may be worse while you are using atenolol, and your allergic reactions may not respond to the usual doses of injectable epinephrine.

If your doctor prescribes a low-salt or low-sodium diet, follow these directions carefully.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Atenolol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dizziness

    • lightheadedness

    • tiredness

    • drowsiness

    • depression

    • nausea

    • diarrhea

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

    • shortness of breath

    • swelling of the hands, feet, ankles, or lower legs

    • weight gain

    • fainting

  • Atenolol may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • lack of energy

  • difficulty breathing

  • wheezing

  • slow heartbeat

  • fainting

  • swelling of the hands, feet, ankles, or lower legs

  • unusual weight gain

  • shakiness

  • dizziness

  • rapid heartbeat

  • sweating or confusion

  • blurred vision

  • headache

  • numbness or tingling of the mouth

  • weakness

  • excessive tiredness

  • pale color

  • sudden hunger

Keep all appointments with your doctor. Your blood pressure should be checked regularly to determine your response to atenolol. Your doctor may ask you to check your pulse (heart rate). Ask your pharmacist or doctor to teach you how to take your pulse. If your pulse is faster or slower than it should be, call your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Tenoretic® (containing Atenolol and Chlorthalidone)

Drug Interaction
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Atenolol.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Atenolol.
Delavirdine Delavirdine The metabolism of Atenolol can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Atenolol can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin Atenolol may decrease the excretion rate of Atorvastatin which could result in a higher serum level.
Dolasetron Dolasetron The metabolism of Dolasetron can be decreased when combined with Atenolol.
Aminophylline Aminophylline The risk or severity of adverse effects can be increased when Atenolol is combined with Aminophylline.
Calcium Carbonate Calcium Carbonate The therapeutic efficacy of Atenolol can be decreased when used in combination with Calcium carbonate.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Atenolol.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole Erythromycin may decrease the excretion rate of Atenolol which could result in a higher serum level.
Fenofibrate Fenofibrate Atenolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Atenolol.
Methylergonovine Methylergonovine Atenolol may increase the vasoconstricting activities of Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Atenolol.
Naratriptan Naratriptan Naratriptan may decrease the antihypertensive activities of Atenolol.
Olsalazine Olsalazine Olsalazine may decrease the antihypertensive activities of Atenolol.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Atenolol.
Penbutolol Penbutolol Acebutolol may increase the arrhythmogenic activities of Atenolol.
Potassium Potassium Potassium may increase the hyperkalemic activities of Atenolol.
Ranitidine Ranitidine The metabolism of Atenolol can be decreased when combined with Ranitidine.
Reserpine Reserpine Reserpine may increase the hypotensive activities of Atenolol.
Rizatriptan Rizatriptan Rizatriptan may decrease the antihypertensive activities of Atenolol.
Sumatriptan Sumatriptan Sumatriptan may decrease the antihypertensive activities of Atenolol.
Tacrolimus Tacrolimus The risk or severity of hyperkalemia can be increased when Atenolol is combined with Tacrolimus.
Tizanidine Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Atenolol.
Zolmitriptan Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Atenolol.
Ampicillin Injection Ampicillin Injection The bioavailability of Atenolol can be decreased when combined with Ampicillin.
Fluconazole Injection Fluconazole Injection The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Atenolol.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Atenolol.
Metoclopramide Injection Metoclopramide Injection The metabolism of Atenolol can be decreased when combined with Metoclopramide.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Atenolol.
Altretamine Altretamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Amphetamine.
Cyclosporine Cyclosporine The metabolism of Atenolol can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Atenolol.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Atenolol is combined with Enoxaparin.
Torsemide Torsemide Torasemide may increase the hypotensive activities of Atenolol.
Olanzapine Olanzapine Atenolol may increase the orthostatic hypotensive activities of Olanzapine.
Dofetilide Dofetilide Dofetilide may increase the arrhythmogenic activities of Atenolol.
Entacapone Entacapone The metabolism of Atenolol can be decreased when combined with Entacapone.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Atenolol.
Meloxicam Meloxicam Meloxicam may decrease the antihypertensive activities of Atenolol.
Telmisartan Telmisartan Atenolol may decrease the excretion rate of Telmisartan which could result in a higher serum level.
Anakinra Anakinra The metabolism of Atenolol can be increased when combined with Anakinra.
Linezolid Linezolid Linezolid may increase the hypotensive activities of Atenolol.
Rivastigmine Rivastigmine Atenolol may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The metabolism of Atenolol can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Atenolol can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate The bioavailability of Atenolol can be increased when combined with Glycopyrronium.
Perindopril Perindopril Atenolol may increase the hypotensive activities of Perindopril.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Atenolol.
Dutasteride Dutasteride Dutasteride may decrease the antihypertensive activities of Atenolol.
Epinephrine Injection Epinephrine Injection The therapeutic efficacy of Epinephrine can be decreased when used in combination with Atenolol.
Eplerenone Eplerenone The risk or severity of hyperkalemia can be increased when Atenolol is combined with Eplerenone.
Escitalopram Escitalopram The serum concentration of Atenolol can be increased when it is combined with Escitalopram.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Atenolol which could result in a higher serum level.
Zonisamide Zonisamide The risk or severity of bradycardia can be increased when Zonisamide is combined with Atenolol.
Adalimumab Injection Adalimumab Injection The metabolism of Atenolol can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Atenolol.
Atomoxetine Atomoxetine The metabolism of Atenolol can be decreased when combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Atenolol.
Ezetimibe Ezetimibe Atenolol may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Atazanavir Atazanavir Atenolol may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Atenolol.
Eletriptan Eletriptan Eletriptan may decrease the antihypertensive activities of Atenolol.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Atenolol.
Rosuvastatin Rosuvastatin Atenolol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Vardenafil Vardenafil Vardenafil may increase the antihypertensive activities of Atenolol.
Alfuzosin Alfuzosin Alfuzosin may increase the hypotensive activities of Atenolol.
Memantine Memantine Memantine may increase the bradycardic activities of Atenolol.
Tegaserod Tegaserod The metabolism of Atenolol can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may increase the antihypertensive activities of Atenolol.
Frovatriptan Frovatriptan Frovatriptan may decrease the antihypertensive activities of Atenolol.
Progesterone Progesterone Progesterone may decrease the excretion rate of Atenolol which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Atenolol.
Infliximab Injection Infliximab Injection The metabolism of Atenolol can be increased when combined with Infliximab.
Protriptyline Protriptyline Protriptyline may decrease the antihypertensive activities of Atenolol.
Rifaximin Rifaximin The metabolism of Atenolol can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Atenolol is combined with Duloxetine.
Tinidazole Tinidazole Atenolol may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium The metabolism of Atenolol can be decreased when combined with Trospium.
Bosentan Bosentan Bosentan may decrease the excretion rate of Atenolol which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Atenolol can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Atenolol.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Atenolol.
Solifenacin Solifenacin Solifenacin may decrease the antihypertensive activities of Atenolol.
Dextroamphetamine Dextroamphetamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Amphetamine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Atenolol can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Atenolol.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Atenolol.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypotensive activities of Atenolol.
Darifenacin Darifenacin The metabolism of Atenolol can be decreased when combined with Darifenacin.
Fentanyl Fentanyl Fentanyl may decrease the antihypertensive activities of Atenolol.
Pregabalin Pregabalin Pregabalin may increase the arrhythmogenic activities of Atenolol.
Phenylephrine Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Atenolol.
Tipranavir Tipranavir The metabolism of Atenolol can be decreased when combined with Tipranavir.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Atenolol.
Ranolazine Ranolazine The serum concentration of Atenolol can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Atenolol can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the hypotensive activities of Atenolol.
Imatinib Imatinib Atenolol may decrease the excretion rate of Imatinib which could result in a higher serum level.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Atenolol.
Varenicline Varenicline The risk or severity of adverse effects can be increased when Atenolol is combined with Varenicline.
Gefitinib Gefitinib The metabolism of Atenolol can be decreased when combined with Gefitinib.
Albuterol Albuterol The therapeutic efficacy of Salbutamol can be decreased when used in combination with Atenolol.
Paliperidone Paliperidone Atenolol may increase the orthostatic hypotensive activities of Paliperidone.
Bortezomib Bortezomib The metabolism of Atenolol can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Atenolol.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Atenolol.
Primaquine Primaquine The metabolism of Atenolol can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection Atenolol may increase the hypotensive activities of Rituximab.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Atenolol is combined with Aliskiren.
Lisdexamfetamine Lisdexamfetamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Lisdexamfetamine.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Atenolol.
Sorafenib Sorafenib The metabolism of Atenolol can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Atenolol.
Mexiletine Mexiletine Atenolol may increase the arrhythmogenic activities of Mexiletine.
Temsirolimus Temsirolimus The metabolism of Atenolol can be decreased when combined with Temsirolimus.
Nilotinib Nilotinib The metabolism of Atenolol can be decreased when combined with Nilotinib.
Budesonide Budesonide Atenolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the antihypertensive activities of Atenolol.
Betaine Betaine Glycine betaine may increase the bradycardic activities of Atenolol.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atenolol.
Desvenlafaxine Desvenlafaxine The serum concentration of Atenolol can be increased when it is combined with Desvenlafaxine.
Cevimeline Cevimeline The risk or severity of adverse effects can be increased when Atenolol is combined with Cevimeline.
Nebivolol Nebivolol Atenolol may increase the arrhythmogenic activities of Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Atenolol.
Pilocarpine Pilocarpine The risk or severity of adverse effects can be increased when Atenolol is combined with Pilocarpine.
Flecainide Flecainide Atenolol may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Atenolol can be increased when combined with Certolizumab pegol.
Silodosin Silodosin Atenolol may increase the orthostatic hypotensive activities of Silodosin.
Milnacipran Milnacipran The serum concentration of Atenolol can be increased when it is combined with Milnacipran.
Sodium Phosphate Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Atenolol.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Atenolol.
Betaxolol Betaxolol Betaxolol may increase the arrhythmogenic activities of Atenolol.
Iloperidone Iloperidone Atenolol may increase the orthostatic hypotensive activities of Iloperidone.
Lacosamide Lacosamide Atenolol may increase the bradycardic activities of Lacosamide.
Everolimus Everolimus The metabolism of Atenolol can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Atenolol is combined with Tolvaptan.
Dronedarone Dronedarone Dronedarone may increase the bradycardic activities of Atenolol.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Atenolol.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Atenolol.
Tapentadol Tapentadol The metabolism of Atenolol can be decreased when combined with Tapentadol.
Golimumab Injection Golimumab Injection The metabolism of Atenolol can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Atenolol.
Asenapine Asenapine Atenolol may increase the orthostatic hypotensive activities of Asenapine.
Pitavastatin Pitavastatin Atenolol may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Atenolol.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Atenolol.
Tocilizumab Injection Tocilizumab Injection The metabolism of Atenolol can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Atenolol may increase the bradycardic activities of Fingolimod.
Lurasidone Lurasidone Lurasidone may decrease the antihypertensive activities of Atenolol.
Acetaminophen Injection Acetaminophen Injection The metabolism of Atenolol can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Atenolol can be decreased when combined with Vilazodone.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atenolol.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Terbutaline can be decreased when used in combination with Atenolol.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Azilsartan medoxomil.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Atenolol.
Rilpivirine Rilpivirine The metabolism of Atenolol can be decreased when combined with Rilpivirine.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Atenolol.
Abiraterone Abiraterone The metabolism of Atenolol can be decreased when combined with Abiraterone.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Atenolol.
Clobazam Clobazam The metabolism of Atenolol can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The metabolism of Atenolol can be decreased when combined with Vemurafenib.
Crizotinib Crizotinib Atenolol may increase the bradycardic activities of Crizotinib.
Cabergoline Cabergoline Atenolol may increase the vasoconstricting activities of Cabergoline.
Ambrisentan Ambrisentan Atenolol may increase the hypotensive activities of Ambrisentan.
Iloprost Iloprost Iloprost may increase the hypotensive activities of Atenolol.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Atenolol.
Regorafenib Regorafenib Regorafenib may increase the bradycardic activities of Atenolol.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Atenolol.
Tofacitinib Tofacitinib Atenolol may increase the bradycardic activities of Tofacitinib.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Atenolol.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Atenolol.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Atenolol.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Atenolol.
Ospemifene Ospemifene The metabolism of Atenolol can be decreased when combined with Ospemifene.
Levomilnacipran Levomilnacipran The serum concentration of Atenolol can be increased when it is combined with Levomilnacipran.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Atenolol.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Atenolol.
Avanafil Avanafil Avanafil may increase the antihypertensive activities of Atenolol.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Atenolol.
Obinutuzumab Injection Obinutuzumab Injection Atenolol may increase the hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Atenolol which could result in a higher serum level.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Atenolol can be increased when used in combination with Dapagliflozin.
Apremilast Apremilast The metabolism of Atenolol can be increased when combined with Apremilast.
Droxidopa Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Atenolol.
Ceritinib Ceritinib Atenolol may increase the bradycardic activities of Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Atenolol can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Atenolol.
Oritavancin Injection Oritavancin Injection The metabolism of Atenolol can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Atenolol can be increased when used in combination with Empagliflozin.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Atenolol.
Methamphetamine Methamphetamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Metamfetamine.
Riociguat Riociguat Atenolol may increase the hypotensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection Atenolol may increase the bradycardic activities of Lanreotide.
Secukinumab Injection Secukinumab Injection The metabolism of Atenolol can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Atenolol may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Atenolol.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Atenolol which could result in a higher serum level.
Naloxegol Naloxegol The metabolism of Atenolol can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Atenolol can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Atenolol.
Haloperidol Injection Haloperidol Injection The serum concentration of Atenolol can be increased when it is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine Atenolol may increase the bradycardic activities of Ivabradine.
Amiloride Amiloride The risk or severity of hyperkalemia can be increased when Atenolol is combined with Amiloride.
Macitentan Macitentan Atenolol may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin Flibanserin may decrease the antihypertensive activities of Atenolol.
Rolapitant Rolapitant The metabolism of Atenolol can be decreased when combined with Rolapitant.
Brexpiprazole Brexpiprazole Atenolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection Atenolol may increase the antihypertensive activities of Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Atenolol.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Atenolol.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Atenolol.
Rifapentine Rifapentine The metabolism of Atenolol can be increased when combined with Rifapentine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol.
Dexamethasone Injection Dexamethasone Injection Dexamethasone may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.
Cobicistat Cobicistat The metabolism of Atenolol can be decreased when combined with Cobicistat.
Midodrine Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Atenolol.
Selexipag Selexipag Atenolol may increase the hypotensive activities of Selexipag.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Atenolol can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the hypotensive activities of Atenolol.
Rucaparib Rucaparib The metabolism of Atenolol can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Atenolol.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Atenolol can be decreased when combined with Doxepin.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Atenolol.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Atenolol.
Safinamide Safinamide Safinamide may increase the hypotensive activities of Atenolol.
Midostaurin Midostaurin The metabolism of Atenolol can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Atenolol can be decreased when combined with Enasidenib.
Letermovir Letermovir Letermovir may decrease the excretion rate of Atenolol which could result in a higher serum level.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Atenolol.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Atenolol.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Atenolol.
Buprenorphine Injection Buprenorphine Injection The metabolism of Atenolol can be decreased when combined with Buprenorphine.
Fostamatinib Fostamatinib Fostamatinib may increase the antihypertensive activities of Atenolol.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Atenolol.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Atenolol.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Atenolol.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Atenolol.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Atenolol.
Cannabidiol Cannabidiol The metabolism of Atenolol can be decreased when combined with Cannabidiol.
Dacomitinib Dacomitinib The metabolism of Atenolol can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Atenolol can be decreased when combined with Stiripentol.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Atenolol may decrease the excretion rate of Paclitaxel which could result in a higher serum level.
Rifamycin Rifamycin The metabolism of Atenolol can be increased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Atenolol can be increased when combined with Emapalumab.
Siponimod Siponimod Siponimod may decrease the antihypertensive activities of Atenolol.
Solriamfetol Solriamfetol Solriamfetol may decrease the antihypertensive activities of Atenolol.
Triclabendazole Triclabendazole The metabolism of Atenolol can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Atenolol.
Pitolisant Pitolisant The metabolism of Atenolol can be decreased when combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Atenolol can be decreased when combined with Fedratinib.
Phenytoin Injection Phenytoin Injection The metabolism of Atenolol can be decreased when combined with Phenytoin.
Lasmiditan Lasmiditan Lasmiditan may increase the bradycardic activities of Atenolol.
Calcium Acetate Calcium Acetate The therapeutic efficacy of Atenolol can be decreased when used in combination with Calcium acetate.
Selpercatinib Selpercatinib Selpercatinib may decrease the antihypertensive activities of Atenolol.
Fenfluramine Fenfluramine The metabolism of Atenolol can be decreased when combined with Fenfluramine.
Octreotide Octreotide The serum concentration of the active metabolites of Atenolol can be increased when Atenolol is used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Atenolol may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Atenolol which could result in a higher serum level.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Atenolol.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Atenolol is combined with Drospirenone.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Atenolol.
Fenoprofen Fenoprofen Fenoprofen may decrease the antihypertensive activities of Atenolol.
Indomethacin Indomethacin Indomethacin may decrease the antihypertensive activities of Atenolol.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Atenolol.
Naproxen Naproxen Naproxen may decrease the antihypertensive activities of Atenolol.
Tolmetin Tolmetin Tolmetin may decrease the antihypertensive activities of Atenolol.
Sulindac Sulindac Sulindac may decrease the antihypertensive activities of Atenolol.
Trazodone Trazodone The serum concentration of Atenolol can be increased when it is combined with Trazodone.
Hydroxyurea Hydroxyurea The metabolism of Atenolol can be decreased when combined with Hydroxyurea.
Phenobarbital Phenobarbital The serum concentration of Atenolol can be decreased when it is combined with Phenobarbital.
Primidone Primidone The serum concentration of Atenolol can be decreased when it is combined with Primidone.
Methsuximide Methsuximide The risk or severity of bradycardia can be increased when Methsuximide is combined with Atenolol.
Diethylpropion Diethylpropion The therapeutic efficacy of Atenolol can be decreased when used in combination with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Atenolol can be decreased when combined with Chlorpromazine.
Phenoxybenzamine Phenoxybenzamine Atenolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Codeine Codeine The metabolism of Atenolol can be decreased when combined with Codeine.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Atenolol.
Metaproterenol Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Atenolol.
Tranylcypromine Tranylcypromine The metabolism of Atenolol can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Phenelzine may increase the hypotensive activities of Atenolol.
Procarbazine Procarbazine Procarbazine may increase the hypotensive activities of Atenolol.
Ergoloid Mesylates Ergoloid Mesylates Atenolol may increase the vasoconstricting activities of Ergoloid mesylate.
Prochlorperazine Prochlorperazine The serum concentration of Atenolol can be increased when it is combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Atenolol can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The serum concentration of Atenolol can be increased when it is combined with Trifluoperazine.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Atenolol.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Atenolol.
Methadone Methadone The metabolism of Atenolol can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Atenolol can be decreased when combined with Oxybutynin.
Benztropine Benztropine The metabolism of Atenolol can be decreased when combined with Benzatropine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Atenolol.
Ibuprofen Ibuprofen Ibuprofen may decrease the antihypertensive activities of Atenolol.
Orphenadrine Orphenadrine The metabolism of Atenolol can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The serum concentration of Atenolol can be increased when it is combined with Perphenazine.
Fluphenazine Fluphenazine The serum concentration of Atenolol can be increased when it is combined with Fluphenazine.
Phentermine Phentermine The therapeutic efficacy of Atenolol can be decreased when used in combination with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the antihypertensive activities of Atenolol.
Amoxapine Amoxapine The metabolism of Atenolol can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Atenolol.
Doxorubicin Doxorubicin Doxorubicin may decrease the excretion rate of Atenolol which could result in a higher serum level.
Mechlorethamine Mechlorethamine Mechlorethamine may increase the bradycardic activities of Atenolol.
Pyridostigmine Pyridostigmine Pyridostigmine may increase the bradycardic activities of Atenolol.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Atenolol.
Clonidine Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Atenolol.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Atenolol.
Hydralazine Hydralazine Atenolol may increase the hypotensive activities of Hydralazine.
Cimetidine Cimetidine The metabolism of Atenolol can be decreased when combined with Cimetidine.
Loperamide Loperamide The risk or severity of bradycardia can be increased when Loperamide is combined with Atenolol.
Promethazine Promethazine The serum concentration of Atenolol can be increased when it is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Atenolol.
Daunorubicin Daunorubicin Atenolol may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Atenolol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Atenolol may increase the arrhythmogenic activities of Digoxin.
Chloroquine Chloroquine The metabolism of Atenolol can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Atenolol can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of bradycardia can be increased when Ethosuximide is combined with Atenolol.
Triamterene Triamterene The risk or severity of hyperkalemia can be increased when Atenolol is combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone Atenolol may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Atenolol.
Metolazone Metolazone Atenolol may increase the hypotensive activities of Metolazone.
Secobarbital Secobarbital The serum concentration of Atenolol can be decreased when it is combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Atenolol.
Amitriptyline Amitriptyline The metabolism of Atenolol can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Atenolol.
Quinidine Quinidine Quinidine may increase the arrhythmogenic activities of Atenolol.
Procainamide Procainamide Atenolol may increase the arrhythmogenic activities of Procainamide.
Rifampin Rifampin The metabolism of Atenolol can be increased when combined with Rifampicin.
Disopyramide Disopyramide Disopyramide may increase the bradycardic activities of Atenolol.
Tamoxifen Tamoxifen The metabolism of Atenolol can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Butabarbital may increase the hypotensive activities of Atenolol.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Atenolol.
Liothyronine Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Atenolol.
Methimazole Methimazole The excretion of Atenolol can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Atenolol.
Glucagon Injection Glucagon Injection The therapeutic efficacy of Atenolol can be decreased when used in combination with Glucagon.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Atenolol.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Atenolol.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Atenolol.
Niacin Niacin The metabolism of Atenolol can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Atenolol.
Clemastine Clemastine The metabolism of Atenolol can be decreased when combined with Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Atenolol can be decreased when combined with Chlorpheniramine.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Atenolol.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Atenolol can be increased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Atenolol.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Atenolol is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Atenolol.
Disulfiram Disulfiram Atenolol may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Atenolol may increase the arrhythmogenic activities of Propranolol.
Minoxidil Minoxidil Atenolol may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Atenolol can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Atenolol can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Atenolol may decrease the excretion rate of Spironolactone which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol.
Mercaptopurine Mercaptopurine The therapeutic efficacy of Mercaptopurine can be decreased when used in combination with Atenolol.
Nadolol Nadolol Atenolol may increase the arrhythmogenic activities of Nadolol.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Atenolol.
Cefaclor Cefaclor Atenolol may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Atenolol can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection Thiotepa may increase the bradycardic activities of Atenolol.
Vincristine Injection Vincristine Injection Atenolol may decrease the excretion rate of Vincristine which could result in a higher serum level.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Captopril.
Dipyridamole Dipyridamole Dipyridamole may increase the bradycardic activities of Atenolol.
Isoxsuprine Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Atenolol.
Vinblastine Vinblastine Vinblastine may decrease the excretion rate of Atenolol which could result in a higher serum level.
Bethanechol Bethanechol The risk or severity of adverse effects can be increased when Atenolol is combined with Bethanechol.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Atenolol.
Metoprolol Metoprolol The metabolism of Atenolol can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The metabolism of Atenolol can be decreased when combined with Hydroxyzine.
Aspirin Aspirin Acetylsalicylic acid may decrease the antihypertensive activities of Atenolol.
Salsalate Salsalate Salsalate may decrease the antihypertensive activities of Atenolol.
Hyoscyamine Hyoscyamine Atenolol may increase the arrhythmogenic activities of Hyoscyamine.
Trimethoprim Trimethoprim The risk or severity of hyperkalemia can be increased when Atenolol is combined with Trimethoprim.
Diltiazem Diltiazem The risk or severity of bradycardia can be increased when Diltiazem is combined with Atenolol.
Nifedipine Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Atenolol.
Timolol Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Atenolol.
Verapamil Verapamil The risk or severity of adverse effects can be increased when Verapamil is combined with Atenolol.
Pindolol Pindolol The risk or severity of hyperkalemia can be increased when Atenolol is combined with Pindolol.
Cisplatin Injection Cisplatin Injection Cisplatin may increase the bradycardic activities of Atenolol.
Diflunisal Diflunisal Diflunisal may decrease the antihypertensive activities of Atenolol.
Piroxicam Piroxicam Piroxicam may decrease the antihypertensive activities of Atenolol.
Bumetanide Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Atenolol.
Glyburide Glyburide The therapeutic efficacy of Atenolol can be increased when used in combination with Glyburide.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Atenolol.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be increased when used in combination with Atenolol.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the hypotensive activities of Atenolol.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Atenolol.
Labetalol Labetalol Atenolol may increase the orthostatic hypotensive activities of Labetalol.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Atenolol.
Ketoprofen Ketoprofen Ketoprofen may decrease the antihypertensive activities of Atenolol.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Atenolol.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Enalapril.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Atenolol.
Amiodarone Amiodarone The therapeutic efficacy of Atenolol can be increased when used in combination with Amiodarone.
Buspirone Buspirone Buspirone may decrease the antihypertensive activities of Atenolol.
Lovastatin Lovastatin Lovastatin may decrease the excretion rate of Atenolol which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the antihypertensive activities of Atenolol.
Diclofenac Diclofenac Diclofenac may decrease the antihypertensive activities of Atenolol.
Fluoxetine Fluoxetine The serum concentration of Atenolol can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of bradycardia can be increased when Nimodipine is combined with Atenolol.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Atenolol.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Atenolol.
Ofloxacin Ofloxacin Atenolol may decrease the excretion rate of Ofloxacin which could result in a higher serum level.
Clarithromycin Clarithromycin Atenolol may decrease the excretion rate of Clarithromycin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Benazepril.
Etodolac Etodolac Etodolac may decrease the antihypertensive activities of Atenolol.
Felodipine Felodipine The risk or severity of bradycardia can be increased when Felodipine is combined with Atenolol.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Fosinopril.
Nabumetone Nabumetone Nabumetone may decrease the antihypertensive activities of Atenolol.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Atenolol which could result in a higher serum level.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Quinapril.
Ramipril Ramipril Ramipril may increase the hypotensive activities of Atenolol.
Simvastatin Simvastatin Atenolol may decrease the excretion rate of Simvastatin which could result in a higher serum level.
Amlodipine Amlodipine The risk or severity of bradycardia can be increased when Amlodipine is combined with Atenolol.
Itraconazole Itraconazole The risk or severity of hyperkalemia can be increased when Atenolol is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Lisinopril.
Oxaprozin Oxaprozin Oxaprozin may decrease the antihypertensive activities of Atenolol.
Sotalol Sotalol Atenolol may increase the arrhythmogenic activities of Sotalol.
Bisoprolol Bisoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Atenolol.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Atenolol.
Doxazosin Doxazosin Atenolol may increase the orthostatic hypotensive activities of Doxazosin.
Terazosin Terazosin Atenolol may increase the orthostatic hypotensive activities of Terazosin.
Isradipine Isradipine The risk or severity of bradycardia can be increased when Isradipine is combined with Atenolol.
Omeprazole Omeprazole The metabolism of Atenolol can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Atenolol can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Atenolol.
Venlafaxine Venlafaxine The metabolism of Atenolol can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine Nizatidine may increase the bradycardic activities of Atenolol.
Fluvoxamine Fluvoxamine The metabolism of Atenolol can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The serum concentration of Atenolol can be increased when it is combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of bradycardia can be increased when Lamotrigine is combined with Atenolol.
Losartan Losartan Atenolol may increase the arrhythmogenic activities of Losartan.
Tramadol Tramadol The metabolism of Atenolol can be decreased when combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Atenolol can be decreased when combined with Vinorelbine.
Moexipril Moexipril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Atenolol can be decreased when combined with Lansoprazole.
Nicardipine Nicardipine The metabolism of Atenolol can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Atenolol can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Atenolol can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir Atenolol may decrease the excretion rate of Saquinavir which could result in a higher serum level.
Metformin Metformin The serum concentration of Metformin can be increased when it is combined with Atenolol.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Atenolol is combined with Dalteparin.
Nisoldipine Nisoldipine The risk or severity of bradycardia can be increased when Nisoldipine is combined with Atenolol.
Amifostine Injection Amifostine Injection Atenolol may increase the hypotensive activities of Amifostine.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Atenolol.
Glimepiride Glimepiride Atenolol may increase the arrhythmogenic activities of Glimepiride.
Indinavir Indinavir Indinavir may decrease the excretion rate of Atenolol which could result in a higher serum level.
Ritonavir Ritonavir The metabolism of Atenolol can be decreased when combined with Ritonavir.
Clomipramine Clomipramine The metabolism of Atenolol can be decreased when combined with Clomipramine.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Atenolol.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Trandolapril.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Atenolol.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Atenolol.
Pramipexole Pramipexole The risk or severity of adverse effects can be increased when Pramipexole is combined with Atenolol.
Donepezil Donepezil Donepezil may increase the bradycardic activities of Atenolol.
Nelfinavir Nelfinavir The metabolism of Atenolol can be decreased when combined with Nelfinavir.
Loratadine Loratadine Atenolol may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The risk or severity of bradycardia can be increased when Atenolol is combined with Carvedilol.
Selegiline Selegiline Selegiline may increase the hypotensive activities of Atenolol.
Bicalutamide Bicalutamide The metabolism of Atenolol can be decreased when combined with Bicalutamide.
Sertraline Sertraline The serum concentration of Atenolol can be increased when it is combined with Sertraline.
Propafenone Propafenone The risk or severity of adverse effects can be increased when Propafenone is combined with Atenolol.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Irbesartan.
Tamsulosin Tamsulosin Atenolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Atenolol.
Finasteride Finasteride Finasteride may decrease the antihypertensive activities of Atenolol.
Quetiapine Quetiapine Atenolol may increase the hypotensive activities of Quetiapine.
Paroxetine Paroxetine The metabolism of Atenolol can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Atenolol.
Citalopram Citalopram The metabolism of Atenolol can be decreased when combined with Citalopram.
Efavirenz Efavirenz Atenolol may decrease the excretion rate of Efavirenz which could result in a higher serum level.
Sildenafil Sildenafil Sildenafil may increase the antihypertensive activities of Atenolol.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Atenolol.
Celecoxib Celecoxib Celecoxib may decrease the antihypertensive activities of Atenolol.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Atenolol can be increased when used in combination with Rosiglitazone.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Atenolol.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Atenolol.
Balsalazide Balsalazide Balsalazide may decrease the antihypertensive activities of Atenolol.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Atenolol.
Galantamine Galantamine Galantamine may increase the bradycardic activities of Atenolol.
Rabeprazole Rabeprazole The metabolism of Atenolol can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Atenolol can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists